OPRA Therapeutics & Patient Care 2027: Topics & MCQs

Therapeutics and Patient Care is the highest-weighted content area in the OPRA exam, accounting for approximately 45% of the examination blueprint published by the Australian Pharmacy Council (APC).

For overseas-qualified pharmacists preparing for the OPRA exam in 2027, understanding this subject is essential. It brings together pharmaceutical science, medication safety, dose calculations, patient assessment and the appropriate use of medicines.

Many candidates focus heavily on memorising drug classifications and mechanisms of action. However, effective preparation also requires understanding how that pharmaceutical knowledge applies to patient-related situations.

This guide explains the OPRA Therapeutics and Patient Care syllabus for 2027, the important topics to revise, common preparation mistakes and original practice MCQs with answers.

What Is Therapeutics and Patient Care in the OPRA Exam?

Therapeutics and Patient Care is one of the five content areas assessed in the Overseas Pharmacist Readiness Assessment (OPRA).

The Australian Pharmacy Council uses this area to assess how candidates apply their knowledge of biomedical and pharmaceutical sciences to patient care.

It includes understanding the appropriate use of medicines, patient assessment, medicine safety, health promotion, treatment monitoring and professional responsibilities.

The subject integrates concepts from pharmacology, pharmacokinetics, pathophysiology and pharmaceutical calculations.

For example, understanding how a medicine works is important, but candidates should also understand how patient factors may affect its safety and appropriate use.

OPRA Exam Therapeutics and Patient Care Weightage

The APC examination blueprint divides OPRA into five main content areas.

Therapeutics and Patient Care has the largest allocation.

However, the 45% figure does not represent a separate passing threshold.

APC determines whether a candidate passes based on overall examination performance, not independent passing scores for individual content areas.

For the complete examination blueprint, read our OPRA Exam Syllabus and Subject Weightage Guide.

Important Topics in OPRA Therapeutics and Patient Care

According to the APC examination guide, this content area includes eight major topic groups.

These sections provide a useful framework for organising revision.

1. Patient Screening and Assessment

Patient screening involves evaluating information that may influence medication decisions.

Relevant calculations include body mass index (BMI) and creatinine clearance.

Candidates should understand how clinical measurements relate to patient care rather than simply memorising formulas.

Example:

A patient weighs 80 kg and has a height of 1.6 metres.

BMI = Weight (kg) ÷ Height (m)²

BMI = 80 ÷ (1.6 × 1.6)

BMI = 31.25 kg/m²

In addition to performing the calculation, understand the limitations of BMI and how patient-specific factors may affect interpretation.

2. Pharmaceutical Dose Calculations

Dose calculations are an important part of Therapeutics and Patient Care.

Topics include:

• Weight-based and body surface area-based dosing

• Drug concentration and dilution

• Ratio and proportion

• Reconstitution of medicines

• Infusion flow rates

• Electrolyte calculations

• Stock solutions and alligation

Candidates should practise identifying the appropriate formula, using consistent units and checking whether a calculated result is reasonable.

For detailed worked examples, explore our OPRA Exam Calculations and Practice MCQs.

3. Primary Health Care and Treatment Options

Primary health care involves understanding appropriate management options for common health conditions.

Candidates should recognise that medicine treatment is not appropriate in every situation.

Some circumstances require non-pharmacological management, further assessment or referral.

For example, understanding when lifestyle interventions may support cardiovascular health is relevant to patient-centred care.

The objective is to connect pharmaceutical knowledge with appropriate health management principles.

4. Medicine Safety in Special Populations

Medicine use requires additional consideration in certain patient groups.

These include:

Older adults: Age-related changes, multiple medicines, adverse effects and medicine-related risks.

Children: Appropriate dose calculations and age-related pharmacological considerations.

Pregnancy: Potential effects of medicines on pregnancy and fetal development.

Breastfeeding: Medicine transfer into breast milk and potential infant exposure.

Candidates should understand that the suitability of a medicine may change according to patient characteristics.

For example, a medicine appropriate for a healthy adult may require additional assessment when the patient has impaired kidney function or is taking interacting medicines.

5. Safe and Effective Use of Medicines

This topic focuses on reviewing and monitoring medication use to support patient safety.

Important concepts include medication adherence, treatment monitoring, medicine-related problems and identification of adverse effects.

Candidates should understand the relationship between a medicine's intended therapeutic effect and its potential risks.

Example:

An older adult reports dizziness after beginning a new medicine.

A useful clinical approach involves considering whether the medicine may contribute to dizziness, reviewing other relevant patient factors and identifying whether further assessment is needed.

The objective is not merely to recognise an adverse effect but also to understand why monitoring and appropriate follow-up matter.

6. Harm Minimisation

Harm minimisation involves approaches that reduce the risk of medicine misuse and medicine-related harm.

Relevant concepts include:

• Recognising potentially harmful medicine use

• Reducing avoidable adverse effects

• Understanding medication dependence and misuse

• Supporting safer medicine use

• Recognising the importance of appropriate patient education

Candidates should focus on the scientific principles of medicine safety and the consequences of inappropriate medication use.

7. Health Promotion and Disease Prevention

Pharmacists also contribute to public health through disease prevention, education and support for healthier behaviours.

Relevant topics include:

• Vaccination principles

• Healthy lifestyle measures

• Smoking cessation

• Appropriate medicine use

• Disease prevention

• Non-pharmacological approaches to health management

For OPRA preparation, connect these topics with underlying biomedical and pharmaceutical principles.

8. Confidentiality and Professionalism

Confidentiality is another topic identified in APC's Therapeutics and Patient Care syllabus.

Candidates should understand general principles concerning the protection of patient information and responsible handling of medicine-related records.

For example, patient medication details should not be disclosed to an unauthorised person without an appropriate legal or professional basis.

Importantly, APC states that OPRA does not assess country-specific pharmacy legislation and practice standards. These are covered in other stages of pharmacist assessment and registration.

How Are Therapeutics Questions Asked in OPRA?

The OPRA examination includes 120 multiple-choice questions completed in 150 minutes.

APC's current examination guide describes three cognitive levels assessed across the examination:

These percentages apply to the examination overall, not exclusively to Therapeutics and Patient Care.

You may encounter questions requiring factual recall, conceptual understanding or application of knowledge to a situation.

Therefore, candidates should not assume that all Therapeutics questions are lengthy patient-case scenarios.

A balanced revision strategy should include direct knowledge questions, interpretation questions and relevant clinical examples.

OPRA Therapeutics and Patient Care Practice MCQs

The following questions are original educational practice examples. They are not official APC examination questions or recalled exam content.

Question 1: Patient Assessment

An adult patient weighs 72 kg and is 1.8 metres tall.

What is the patient's approximate body mass index?

a) 18.5 kg/m²
b) 22.2 kg/m²
c) 25.8 kg/m²
d) 30.1 kg/m²

Correct answer: b) 22.2 kg/m²

Explanation:

BMI = Weight ÷ Height²

BMI = 72 ÷ (1.8 × 1.8)

BMI = 72 ÷ 3.24 = 22.2 kg/m².

This question assesses the calculation of a common screening parameter.

Question 2: Medication Safety

A 78-year-old patient experiences new dizziness and daytime drowsiness after beginning a sedating antihistamine.

Which response is MOST appropriate?

a) Assume the symptoms are unrelated to medication
b) Recommend taking an additional dose
c) Assess possible medicine-related sedation and fall risk
d) Ignore the symptoms until the next prescription refill

Correct answer: c) Assess possible medicine-related sedation and fall risk

Explanation:

Sedating medicines can contribute to drowsiness and falls, particularly in older adults.

Medication review and appropriate clinical follow-up may be necessary to identify safer management options.

Question 3: Drug Interactions

A patient takes an ACE inhibitor and a diuretic. The patient asks about regularly using an oral NSAID for pain.

Which potential complication deserves particular attention?

a) Increased vitamin absorption
b) Acute kidney injury
c) Increased red blood cell production
d) Reduced absorption of dietary protein

Correct answer: b) Acute kidney injury

Explanation:

The combination of an ACE inhibitor or angiotensin receptor blocker, a diuretic and an NSAID can increase the risk of acute kidney injury.

Understanding medicine interactions and patient-specific risk factors is important for safe medicine use.

Question 4: Medicine Allergy

A patient reports a previous immediate severe allergic reaction to amoxicillin. A new prescription is written for amoxicillin.

What is the MOST appropriate initial action?

a) Dispense the medicine without further assessment
b) Ignore the documented allergy
c) Clarify the allergy history and contact the prescriber before dispensing
d) Recommend doubling the dose

Correct answer: c) Clarify the allergy history and contact the prescriber before dispensing

Explanation:

A previous severe immediate reaction to the same medicine raises an important safety concern.

The allergy history and prescription should be reviewed before the medicine is supplied.

Question 5: Medication Adherence

A patient repeatedly uses an inhaler incorrectly despite receiving written instructions.

Which approach is MOST likely to help assess and improve the patient's technique?

a) Provide the same leaflet without discussion
b) Demonstrate the technique and ask the patient to show how they use it
c) Assume the patient understands the instructions
d) Discontinue all inhaled medicines without review

Correct answer: b) Demonstrate the technique and ask the patient to show how they use it

Explanation:

Demonstration followed by a return demonstration can help identify technique errors and confirm patient understanding.

This question illustrates the importance of medicine-use education and adherence support.

Question 6: Confidentiality

A person requests another patient's medication history but has no documented authorisation or appropriate legal basis to access it.

What is the MOST appropriate response?

a) Share the information because the requester knows the patient
b) Provide the complete medication history
c) Decline unauthorised disclosure and follow the applicable confidentiality process
d) Send the information to the requester's personal email

Correct answer: c) Decline unauthorised disclosure and follow the applicable confidentiality process

Explanation:

Patient medication information must be handled according to confidentiality and professional obligations.

Information should not be shared merely because someone requests it.

How to Prepare for Therapeutics and Patient Care in OPRA 2027

A practical preparation strategy should combine conceptual learning, question practice and regular revision.

Step 1: Start With the Official Blueprint

Review the eight syllabus topic groups and identify which areas you understand well.

Use the published outline as a checklist.

Step 2: Connect Pharmacology With Patient Care

When studying a medicine, consider its mechanism, potential adverse effects, important interactions and patient-related precautions.

This helps connect pharmaceutical science with therapeutic applications.

Step 3: Practise Calculations Regularly

Include short sessions involving BMI, dosing, concentrations, dilutions and infusion calculations.

Check units and review mistakes carefully.

Step 4: Study Special-Population Considerations

Pay attention to age-related and physiological differences that may influence medicine safety.

Understand general principles rather than relying on isolated memorised recommendations.

Step 5: Use Different Types of MCQs

Practise recall questions, conceptual questions and application-based scenarios.

This better reflects the range of cognitive abilities described by APC.

Step 6: Review Incorrect Answers

Maintain an error journal containing:

• The topic you missed

• The reason for your mistake

• The correct underlying concept

• A date to revisit the topic

Regular error analysis can make revision more targeted.

Seven-Day Therapeutics Revision Timetable

The following plan can help candidates organise a first revision cycle.

This schedule is a suggested learning framework rather than an official APC study plan.

For broader exam preparation, read our 12-Week OPRA Exam Study Plan for Working Pharmacists.

Common Mistakes to Avoid While Preparing for Therapeutics

Memorising medicine names without understanding their effects: Candidates should understand the pharmacological principles behind medicine use.

Ignoring patient-specific factors: Age, pregnancy, breastfeeding, kidney function and other patient characteristics can affect medicine safety.

Avoiding numerical questions: Screening and dose calculations are explicitly included in the syllabus.

Focusing only on case-based questions: The examination also includes substantial recall and comprehension content.

Ignoring the other OPRA subjects: Although Therapeutics and Patient Care has the largest weightage, the overall passing standard applies across the full examination.

Test Your OPRA Preparation Level

After revising Therapeutics and Patient Care, assess your broader pharmaceutical science knowledge.

You can use our Free 20-Question OPRA Readiness Quiz to identify areas that may need further study.

You can also explore Free OPRA Sample Papers for additional independent practice.

Need guidance planning your OPRA preparation?

Use the enquiry form on opraxam.in to request free OPRA preparation guidance.

The quiz and practice questions are independent learning resources and do not provide a validated prediction of an official examination result.

Conclusion

OPRA Therapeutics and Patient Care preparation for 2027 should focus on understanding how pharmaceutical and biomedical knowledge supports appropriate and safe medicine use.

With approximately 45% of the examination blueprint allocated to this subject area, candidates should give it meaningful attention in their study timetable.

Revise the official eight topic groups, practise pharmaceutical calculations, understand patient-specific safety considerations and use a combination of recall, comprehension and application-based questions.

Most importantly, prepare across the entire OPRA syllabus rather than focusing only on one content area.

Start with the official blueprint, use suitable practice questions and identify your knowledge gaps before planning further revision.

Explore More OPRA Preparation Resources

• OPRA Exam Syllabus and Weightage

• Free OPRA Sample Papers

• OPRA Pharmaceutical Calculations and Practice MCQs

• 12-Week OPRA Study Plan

• Free OPRA Readiness Quiz

Official References

1. Australian Pharmacy Council — OPRA Exam Guide and Sample Content

2. Australian Pharmacy Council — Knowledge Stream

Last reviewed: 28 October 2026

Disclaimer: opraexam.in is an independent educational website and is not affiliated with or endorsed by the Australian Pharmacy Council. This article is intended for examination preparation and does not provide patient-specific clinical advice. Examination requirements may change; verify current information with APC.